Patents Examined by Brian T. Gedeon
  • Patent number: 11484216
    Abstract: A modular wearable health monitor having a substantially flexible attachment means connected to a housing comprising a power source and at least one processor through a relatively rigid and narrow spine disposed substantially centrally thereon having a variety of clinical and non-clinical uses that provides more comfortable and durable attachment of biometric sensors to a user by allowing the attachment means to contour to the user's body without the housing also being forced to do so along its entire width.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: November 1, 2022
    Assignee: BraveHeart Wireless Inc.
    Inventors: Stephen A McCalmont, Stuart P. MacEachern, Sharon Lake
  • Patent number: 11484200
    Abstract: A light adjustable lens illumination system comprises an illumination source, for generating a light beam; a light delivery system, for projecting the light beam onto a Light Adjustable Lens (LAL), implanted into an eye, wherein a fraction of the light beam propagates past the LAL to a retina of the eye; and a protective beam-shaper, for shaping the light beam to have an intensity pattern with a relative central intensity reduction that varies along an axis; wherein the relative central intensity reduction at the retina is greater than the relative central intensity reduction at a LAL plane.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: November 1, 2022
    Assignee: RxSight, Inc.
    Inventors: John Kondis, Robert Maloney, Ilya Goldshleger, Matt Haller, Christian A. Sandstedt
  • Patent number: 11478658
    Abstract: A circadian rhythm entrainment platform can use medication circadian profiles that include mappings of medications to circadian rhythm disruptions and can make conversions of such circadian rhythm disruptions to administrations of light therapy to adjust for the disruptions. The circadian rhythm entrainment platform can specify how to entrain a patient's circadian rhythm using light therapy to compensate for or anticipate side effects of medications and for optimizing medication schedules for a patient's circadian rhythm so as to minimize side effects and increase medication effectiveness. The circadian rhythm entrainment platform can also gather information on the effects of medications on circadian rhythms and interact with patients, medical providers, and other providers in relation to light therapy.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: October 25, 2022
    Inventor: Larry V. Pederson
  • Patent number: 11478655
    Abstract: Concepts and technologies disclosed herein are directed to a smart automated external defibrillator (“AED”). According to one aspect of the concepts and technologies disclosed herein, the AED can present a menu that includes a plurality of modes. The plurality of modes can include a first responder mode, an Internet of Things (“IoT”) mode, and a general use mode. The AED can receive, via an input component, a selection, from the menu, of a mode from the plurality of modes. In response to the selection, the AED can configure a network connectivity component in accordance with a setting specified in the mode.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: October 25, 2022
    Assignee: AT&T Intellectual Property I, L.P.
    Inventors: James Gordon Beattie, Jr., Haywood S. Peitzer
  • Patent number: 11471691
    Abstract: Embodiments herein relate to implantable medical devices including a power subunit with a first biocompatible electrically conductive shell configured for direct contact with an in vivo environment. In some embodiments a lithium anode can be disposed within the first biocompatible electrically conductive shell in direct electrical communication with a feedthrough pin, wherein the feedthrough pin is electrically isolated from the first biocompatible electrically conductive shell. A cathode can also be disposed within the first biocompatible electrically conductive shell and can be in direct electrical communication with the first biocompatible electrically conductive shell. The first biocompatible electrically conductive shell has a positive electrical potential. The implantable medical device further includes an electronics control subunit with a control circuit disposed within a second biocompatible electrically conductive shell. Other embodiments are included herein.
    Type: Grant
    Filed: January 23, 2020
    Date of Patent: October 18, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Troy Anthony Giese, Ignacio Chi, Michael J. Root, Larry Michael Killeen
  • Patent number: 11471697
    Abstract: A computerized method for controlling the operation of a laser therapy device is disclosed. A laser therapy device comprising laser diodes has a microprocessor for storing and executing instructions pertaining to the operation of the laser diodes within certain parameters. The computerized method detects the movement of the laser therapy device and alters the output of the laser diodes when a movement signal exceeds predetermined threshold parameters. The computerized method detects difference in temperature in certain areas, and patterns in temperature differences, for assistance in diagnosing ailments. The computerized method also detects differences in skin color to determine treatment areas. The computerized method also measures the distance of the laser therapy device to a treatment area. The microprocessor executes instructions then which can alter the output of the laser diodes or generate an alarm signal based on measurements received.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: October 18, 2022
    Inventor: Andrew Hewitson
  • Patent number: 11474483
    Abstract: A consumer product that is a portable and, in some cases, a wearable electronic device. The wearable electronic device may have functionalities including: keeping time; monitoring a user's physiological signals and providing health-related information based on those signals; communicating with other electronic devices or services; visually depicting data on a display; gather data form one or more sensors that may be used to initiate, control, or modify operations of the device; determine a location of a touch on a surface of the device and/or an amount of force exerted on the device, and use either or both as input.
    Type: Grant
    Filed: February 15, 2022
    Date of Patent: October 18, 2022
    Assignee: APPLE INC.
    Inventors: Fletcher R. Rothkopf, Jonathan Ive, Julian Hoenig, Rico Zorkendorfer
  • Patent number: 11464445
    Abstract: Provided is a data processing apparatus including a signal data processor configured to collect signal data detected through polysomnography, to extract feature data by analyzing a feature of the collected signal data, and to transform the extracted feature data to time series data; and a sleep stage classification model processor configured to input the processed signal data to a pre-generated sleep stage classification model, and to classify a sleep stage corresponding to the signal data. The signal data processor is configured to extract feature data by analyzing a feature of each of an electroencephalographic (EEG) signal, an electro-oculographic (EOG) signal, and an electromyographic (EMG) signal with respect to the signal data, and to transform the extracted feature data to an epoch unit of time series data to input the extracted feature data to the pre-generated sleep stage classification model.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: October 11, 2022
    Assignee: HONEYNAPS CO., LTD.
    Inventors: Young Jun Lee, Tae Kyoung Ha
  • Patent number: 11464982
    Abstract: Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) and an extracardiac device (ED). The LCP is configured to deliver pacing therapy at a pacing interval. Illustratively, the ED may be configured to analyze the cardiac cycle including a portion preceding the pacing therapy delivery for one or several cardiac cycles, and determine whether an interval from the P-wave to the pace therapy in the cardiac cycle(s) is in a desired range. In an example, if the P-wave to pace interval is outside the desired range, the ED communicates to the LCP to adjust the pacing interval.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: October 11, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Stephen J. Hahn, Krzysztof Z. Siejko, Amy Jean Brisben, Keith R. Maile
  • Patent number: 11458319
    Abstract: Systems and methods for pacing cardiac conductive tissue are described. An embodiment of a medical system includes an electrostimulation circuit to generate His-bundle pacing (HBP) pulses to stimulate a His bundle, and a cardiac event detector to detect a His-bundle activity within a time window following an atrial activity. The cardiac event detector may use a cross-chamber blanking, or an adjustable His-bundle sensing threshold, to avoid or reduce over-sensing of far-field atrial activity and inappropriate inhibition of HBP therapy. The electrostimulation circuit may deliver HBP in the presence of the His-bundle activity. The system may further recognize the detected His-bundle activity as either a FFPW or a valid inhibitory event, and deliver or withhold HBP therapy based on the recognition of the His-bundle activity.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: October 4, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: David Arthur Casavant, David L. Perschbacher, Deepa Mahajan
  • Patent number: 11457873
    Abstract: One variation of a method for identifying homology of physiological signals comprises: receiving signal data of two different types of physiological signals; performing waveform matching on the signal data of the two different types of physiological signals to determine waveform matching information in the signal data of the two types of physiological signals; calculating an associative feature between the signal data of the two different types of physiological signals according to the waveform matching information; calculating a homology reference coefficient corresponding to the two different types of physiological signals according to the associative feature; and determining that the two different types of physiological signals are homologous when the homology reference coefficient is greater than a preset value.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: October 4, 2022
    Assignee: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    Inventors: Sanchao Liu, Jianwei Su, Zehui Sun, Bailei Sun, Wenyu Ye, Lihan Liu, Ming Li
  • Patent number: 11458325
    Abstract: Devices, systems and methods are provided for treating a disease or disorder in a patient. The methods include positioning a surface of a housing in contact with an outer skin surface of the patient and applying sufficient energy to an energy transmitter within the housing via a power supply to generate an electrical impulse at or near a vagus nerve of the patient. The electrical impulse is sufficient to modulate fibers of the vagus nerve and treat the disease or disorder.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: October 4, 2022
    Assignee: ELECTROCORE, INC
    Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle, Steven Mendez
  • Patent number: 11452883
    Abstract: A hands-free LED device for the treatment of wrinkles and acne, or hair loss, includes a curved housing. Rigid areas contain the LED bulbs. The LED bulbs are interspaced therebetween the flexible areas; such that between each of the rigid LED bulb areas is a flexible area. The rigid LED bulb areas are between the flexible areas. A leg is provided on opposite sides of the housing, The legs being wider at the top of each leg and narrower at the bottom. The number of LED bulbs at each wavelength for treatment of wrinkles are: 126 LED bulbs of 605 nm; 210 LED bulbs of 630 nm, 126 LED bulbs of 660 nm, and 26 LED bulbs of 850 nm. The number of LED bulbs at each wavelength for treatment of acne are 280 LED bulbs at 415 nm and 210 LED bulbs of 630 nm. Hair loss uses 500-700 LED bulbs at 630 nm.
    Type: Grant
    Filed: February 25, 2022
    Date of Patent: September 27, 2022
    Inventors: Stephen James Marchese, Chasen James Marchese
  • Patent number: 11445922
    Abstract: In one aspect, a photoplethysmograph system to measure a user's heart rate includes one or more light-emitting diodes (LED) that provide a constantly-on light signal during a measurement period. The one or more light-emitting diodes are in optical contact with an epidermal surface of the user. The one or more light-emitting diodes emit a light signal into the tissue of the user, and wherein the tissue contains a pulsating blood flow. A light-intensity sensor circuit converts the reflected LED light from the tissue into a second signal that is proportional to a reflected light intensity. The second signal includes a voltage or current signal. A computer-processing module calculates the user's beat-to-beat heart rate from the second current signal.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: September 20, 2022
    Assignee: TERUMO KABUSHIKI KAISHA
    Inventor: Reza Naima
  • Patent number: 11446489
    Abstract: A method to treat a patient having a pelvic floor dysfunction by establishing a neurostimulator having a processor and a signal generator to generate a stimulation signal. The processor is set to one or more parameters effective in the treating of the patient's pelvic dysfunction when the stimulation signal is applied to a saphenous nerve of the patient. The neurostimulator is configured to provide the stimulation signal to a stimulator in accordance with a stimulation protocol. At least one stimulator is positioned next to a portion of the saphenous nerve of at least one lower limb of a patient. The processor is operationally activated to provide the stimulation signal to the stimulator for treatment of the patient.
    Type: Grant
    Filed: June 23, 2020
    Date of Patent: September 20, 2022
    Assignee: EBT Medical, Inc.
    Inventors: Paul B. Yoo, Michael Sasha John
  • Patent number: 11446480
    Abstract: An implantable pump system is provided, suitable for use as a left ventricular assist device (LVAD) system, having an implantable pump, a battery, a controller, and a programmer. The implantable pump includes a flexible membrane coupled to an actuator assembly via a skirt that extends toward the inlet of the pump and curves to guide blood toward the outlet. The actuator assembly is magnetically engagable with electromagnetic coils, so that when the electromagnetic coils are energized, the actuator assembly causes wavelike undulations to propagate along the flexible membrane to propel blood from the inlet, across the skirt, and through the outlet of the implantable pump. The controller may be programmed by a programmer to operate at frequencies and duty cycles that mimic physiologic flow rates and pulsatility while operating in an efficient manner that avoids thrombus formation, hemolysis and/or platelet activation.
    Type: Grant
    Filed: November 22, 2018
    Date of Patent: September 20, 2022
    Assignee: CorWave SA
    Inventors: Luc Polverelli, Leopold Maine, Carl N. Botterbusch, Silvere Lucquin, Jean-Baptiste Drevet, Adrien Guignabert, Patrick Meneroud, Alexandra Schmidt, Pier-Paolo Monticone
  • Patent number: 11446510
    Abstract: A leadless pacing device may include a housing having a proximal end and a distal end, and one or more electrodes supported by the housing. The housing may include a body portion and a header. A distal extension may extend distally from the header of the housing, the distal extension including one or more electrodes. The header may include a guide wire port and a guide wire lumen may extend from the guide wire port through the header of the housing and through the distal extension. A fixation member may extend from the header of the housing. The header may be formed from an over mold process.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: September 20, 2022
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Lili Liu, Benjamin J. Haasl, Brendan Early Koop, Arthur J. Foster, Justin Robert Alt, Dana Sachs
  • Patent number: 11446505
    Abstract: Systems and methods for dynamically controlling His-bundle pacing (HBP) according to an indication of a rate-related or intermittent atrioventricular (AV) block in a subject are disclosed. An exemplary medical system includes an AV conduction monitor to detect an indication of either a presence or an absence of intermittent or rate-related AV conduction disturbance using physiologic information of the subject. In the event that an intermittent or rate-related AV conduction disturbance is present, a control circuit provides a control signal to an electrostimulation circuit to deliver HBP pulses. If there is no indication of intermittent or rate-related AV conduction disturbance, or a previously detected intermittent or rate-related AV conduction disturbance has been terminated, the control circuit withholds or discontinues delivery of the HBP pulses to promote intrinsic ventricular conduction and activation.
    Type: Grant
    Filed: May 28, 2020
    Date of Patent: September 20, 2022
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Allan Charles Shuros, David Arthur Casavant
  • Patent number: 11445970
    Abstract: A system and method for neural-network-based atrial fibrillation detection with the aid of a digital computer are provided. Electrocardiography (ECG) features and annotated patterns of the features are maintained in a database, at least some of the patterns associated with atrial fibrillation. A classifier is trained based on the annotated patterns, the classifier implemented by a convolutional neural network. A representation of an ECG signal recorded by one or more ambulatory monitors is received. ECG features in the representation falling within each of the temporal windows are detected. The trained classifier is used to identify patterns of the ECG features. At least one matrix with weights for the patterns are generated. A value indicative of whether portions of the representation are associated the patient experiencing atrial fibrillation is calculated. That one or more of the portions are associated with the patient experiencing atrial fibrillation is determined.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: September 20, 2022
    Assignee: Bardy Diagnostics, Inc.
    Inventors: Rodney Boleyn, Ezra M. Dreisbach, Chuck Dulken, Gust H. Bardy
  • Patent number: 11445928
    Abstract: Methods, systems, and apparatus for detecting configuration for a patient worn sensor assembly are described. In one aspect a method includes receiving, by a computer system, sensor assembly data for a particular sensor assembly, accessing, by the computer system, sensor assembly identifier information defining a plurality of sensor assembly identifiers, where each sensor assembly identifier is associated with a respective sensor assembly, identifying, by the computer system and based on the sensor assembly data, a particular sensor assembly identifier for the particular sensor assembly, and determining, by the computer system, configuration information for the particular sensor assembly based on the particular sensor assembly identifier.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 20, 2022
    Assignee: MURATA VIOS, INC.
    Inventors: Benjamin David Meyer, Scott Thomas Mazar